Spots Global Cancer Trial Database for stage ii bladder cancer
Every month we try and update this database with for stage ii bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | NCT00380029 | Bladder Cancer | Erlotinib Radical Cystect... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium | NCT00082719 | Bladder Cancer Urethral Cancer | Recombinant Int... | - | M.D. Anderson Cancer Center | |
| 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | NCT01124682 | Bladder Cancer | diagnostic cyst... diffusion-weigh... implanted fiduc... quality-of-life... 3-dimensional c... image-guided ra... selective exter... | 18 Years - | National Cancer Institute (NCI) | |
| S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium | NCT00045630 | Bladder Cancer Transitional Ce... Urethral Cancer | carboplatin gemcitabine paclitaxel surgery | 18 Years - | SWOG Cancer Research Network | |
| Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003642 | Bladder Cancer | cisplatin fluorouracil radiation thera... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | NCT00380029 | Bladder Cancer | Erlotinib Radical Cystect... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003930 | Bladder Cancer | cisplatin gemcitabine hyd... paclitaxel conventional su... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | NCT00033436 | Bladder Cancer | niacinamide carbogen radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection | NCT00303654 | Bladder Cancer | biopsy therapeutic con... | - | National Cancer Institute (NCI) | |
| Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003642 | Bladder Cancer | cisplatin fluorouracil radiation thera... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003640 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... surgical proced... radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery | NCT00777491 | Bladder Cancer | induction cispl... induction 5-flu... induction gemci... Induction BID r... Induction QD ra... Consolidation B... Consolidation Q... consolidation g... consolidation 5... consolidation c... radical cystect... Post-Induction ... adjuvant gemcit... adjuvant cispla... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery | NCT00268450 | Bladder Cancer | bevacizumab cisplatin gemcitabine hyd... paclitaxel cysectomy | 18 Years - 120 Years | Medical University of South Carolina | |
| Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer | NCT01611662 | Distal Urethral... Proximal Urethr... Squamous Cell C... Stage II Bladde... Stage III Bladd... Urethral Cancer... | gemcitabine hyd... cisplatin therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery | NCT01108003 | Recurrent Bladd... Stage 0 Bladder... Stage I Bladder... Stage II Bladde... Transitional Ce... | broccoli sprout... laboratory biom... Mango Juice | 18 Years - | Roswell Park Cancer Institute | |
| Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery | NCT00268450 | Bladder Cancer | bevacizumab cisplatin gemcitabine hyd... paclitaxel cysectomy | 18 Years - 120 Years | Medical University of South Carolina | |
| Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer | NCT01196403 | Bladder Cancer | questionnaire a... quality-of-life... robot-assisted ... therapeutic con... therapeutic lap... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer | NCT01611662 | Distal Urethral... Proximal Urethr... Squamous Cell C... Stage II Bladde... Stage III Bladd... Urethral Cancer... | gemcitabine hyd... cisplatin therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder | NCT00084578 | Bladder Cancer | celecoxib rosiglitazone m... conventional su... neoadjuvant the... | 18 Years - | Fox Chase Cancer Center | |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer | NCT00003167 | Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Transitional Ce... | Ad5CMV-p53 gene | 18 Years - | National Cancer Institute (NCI) | |
| 3 Tesla MRI in Patients With Bladder Cancer | NCT00938145 | Bladder Cancer | Specimen Ultra-... chemotherapy Cystectomy and ... | 18 Years - | University of Cincinnati | |
| S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer | NCT01224665 | Bladder Cancer | therapeutic con... therapeutic sta... therapeutic ext... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | NCT00072137 | Bladder Adenoca... Bladder Squamou... Bladder Urothel... Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Recombinant Fow... Recombinant Fow... Therapeutic Con... Pharmacological... Laboratory Biom... | - | National Cancer Institute (NCI) | |
| Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer | NCT00054626 | Bladder Cancer | cisplatin gemcitabine hyd... adjuvant therap... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | NCT01938573 | Recurrent Bladd... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Cisplatin Gemcitabine Hyd... Sirolimus Cystectomy | 18 Years - | University of Washington | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | NCT00900276 | Bladder Cancer Kidney Cancer Transitional Ce... Urethral Cancer | immunologic tec... laboratory biom... mass spectromet... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection | NCT00303654 | Bladder Cancer | biopsy therapeutic con... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | NCT00055601 | Bladder Cancer | cisplatin fluorouracil paclitaxel radiation thera... Gemcitabine Radical cystect... | - 120 Years | Radiation Therapy Oncology Group | |
| Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003640 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... surgical proced... radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | NCT00072137 | Bladder Adenoca... Bladder Squamou... Bladder Urothel... Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Recombinant Fow... Recombinant Fow... Therapeutic Con... Pharmacological... Laboratory Biom... | - | National Cancer Institute (NCI) | |
| Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery | NCT00268450 | Bladder Cancer | bevacizumab cisplatin gemcitabine hyd... paclitaxel cysectomy | 18 Years - 120 Years | Medical University of South Carolina | |
| Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer | NCT00666562 | Stage I Bladder... Stage II Bladde... Stage III Bladd... | Defined Green T... Laboratory Biom... Pharmacological... Placebo Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | NCT01938573 | Recurrent Bladd... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Cisplatin Gemcitabine Hyd... Sirolimus Cystectomy | 18 Years - | University of Washington | |
| Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | NCT00867347 | Bladder Cancer | therapeutic con... radiation thera... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium | NCT00045630 | Bladder Cancer Transitional Ce... Urethral Cancer | carboplatin gemcitabine paclitaxel surgery | 18 Years - | SWOG Cancer Research Network | |
| R115777 in Treating Patients With Advanced Bladder Cancer | NCT00006376 | Bladder Cancer Transitional Ce... | chemotherapy tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | NCT00055601 | Bladder Cancer | cisplatin fluorouracil paclitaxel radiation thera... Gemcitabine Radical cystect... | - 120 Years | Radiation Therapy Oncology Group | |
| MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer | NCT02735512 | No Evidence of ... Stage II Bladde... Stage III Bladd... Stage IVA Bladd... Stage IVB Bladd... | Cytology Specim... Laboratory Biom... | - | University of Southern California | |
| Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | NCT00006105 | Bladder Cancer Drug/Agent Toxi... | amifostine trih... cisplatin gemcitabine hyd... adjuvant therap... | 18 Years - | University of Chicago | |
| Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | NCT00006105 | Bladder Cancer Drug/Agent Toxi... | amifostine trih... cisplatin gemcitabine hyd... adjuvant therap... | 18 Years - | University of Chicago | |
| Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | NCT00033436 | Bladder Cancer | niacinamide carbogen radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Ask Questions (ASQ):Implementation of a Communication Intervention | NCT05025748 | Stage II Breast... Stage III Breas... Stage IV Breast... Stage II Colore... Stage III Color... Stage IV Colore... Stage II Lung C... Stage III Lung ... Stage IV Lung C... Stage II Prosta... Stage III Prost... Stage IV Prosta... Stage II Ovaria... Stage III Ovari... Stage IV Ovaria... Stage II Cervic... Stage III Cervi... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Stage II Kidney... Stage III Kidne... Stage IV Kidney... | Behavioral Inte... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer | NCT00003167 | Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Transitional Ce... | Ad5CMV-p53 gene | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder | NCT01222676 | Bladder Cancer | cisplatin gemcitabine hyd... sorafenib tosyl... imaging biomark... laboratory biom... computed tomogr... neoadjuvant the... fludeoxyglucose... | 18 Years - | National Cancer Institute (NCI) | |
| Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery | NCT01108003 | Recurrent Bladd... Stage 0 Bladder... Stage I Bladder... Stage II Bladde... Transitional Ce... | broccoli sprout... laboratory biom... Mango Juice | 18 Years - | Roswell Park Cancer Institute | |
| 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer | NCT00005047 | Bladder Cancer | cisplatin doxorubicin hyd... methotrexate vinblastine | - 120 Years | SWOG Cancer Research Network | |
| Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | NCT00006111 | Bladder Cancer Transitional Ce... Urethral Cancer | cisplatin fluorouracil conventional su... radiation thera... | 18 Years - 70 Years | UNICANCER | |
| Quality of Life in Patients With Bladder Cancer | NCT00553215 | Bladder Cancer | quality-of-life... questionnaire a... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer | NCT00002919 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... conventional su... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer | NCT00553124 | Bladder Cancer | selenium vitamin E biopsy chemoprevention cryopreservatio... cytology specim... diagnostic proc... gene expression... immunohistochem... laboratory biom... medical chart r... mutation analys... polymerase chai... quality-of-life... questionnaire a... study of socioe... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib in Treating Patients With Locally Advanced Bladder Cancer | NCT00526656 | Bladder Cancer | sunitinib malat... | 18 Years - | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
